Evidence map›Paper›PMID 32327570›Full record

ReviewScience (New York, N.Y.)2020

The integrated stress response: From mechanism to disease.

Mauro Costa-Mattioli, Peter Walter

Abstract readReview
In one paragraph

Review in Science (New York, N.Y.), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 967 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
967citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

967 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Trial
  3. Article
  4. Review
  5. Article
  6. Review
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Dissecting the cell biology of the ISR in cognitive disorders at the single-cell resolution.Proceedings of the National Academy of Sciences of the United States of America · 2026
    Article
  18. Article
  19. Prion-Like Protein LENG8-Mediated Nucleation Drives Stress Granule Assembly.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026
    Article
  20. Review

907 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Mauro Costa-MattioliDepartment of Neuroscience, Memory and Brain Research Center, Baylor College of Medicine, Houston, TX, USA. costamat@bcm.edu peter@walterlab.ucsf.edu.ORCID 0000-0002-9809-4732
Peter WalterHoward Hughes Medical Institute and Department of Biochemistry and Biophysics, University of California at San Francisco, San Francisco, CA, USA. costamat@bcm.edu peter@walterlab.ucsf.edu.ORCID 0000-0002-6849-708X

Funding

The integrated stress response in cognitive disordersR01NS076708 · NINDS · BAYLOR COLLEGE OF MEDICINE · PI PFAFFINGER, PAUL, RAY, RUSSELL S · 2012 to 2025
$7.9M
Howard Hughes Medical Institute,NINDS NIH HHS R01 NS076708
6 · The paper itself

Abstract

Protein quality control is essential for the proper function of cells and the organisms that they make up. The resulting loss of proteostasis, the processes by which the health of the cell's proteins is monitored and maintained at homeostasis, is associated with a wide range of age-related human diseases. Here, we highlight how the integrated stress response (ISR), a central signaling network that responds to proteostasis defects by tuning protein synthesis rates, impedes the formation of long-term memory. In addition, we address how dysregulated ISR signaling contributes to the pathogenesis of complex diseases, including cognitive disorders, neurodegeneration, cancer, diabetes, and metabolic disorders. The development of tools through which the ISR can be modulated promises to uncover new avenues to diminish pathologies resulting from it for clinical benefit.

Indexed as

ProteostasisStress, PhysiologicalAcetamidesAnimalsCyclohexylaminesEukaryotic Initiation Factor-2HumansImmunityMetabolic DiseasesMiceNeoplasmsPhosphotransferasesTernary Complex Factors2-(4-chlorophenoxy)-N-(4-(2-(4-chlorophenoxy)acetamido)cyclohexyl)acetamideAcetamidesCyclohexylaminesEukaryotic Initiation Factor-2PhosphotransferasesTernary Complex Factors

Identifiers

PMID32327570
PMCPMC8997189

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.